NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,862 | +8.3% | 2,708 | +7.3% | 0.30% | +13.7% |
| Q2 2023 | $254,621 | +9.7% | 2,523 | 0.0% | 0.26% | +6.1% |
| Q1 2023 | $232,139 | +1.4% | 2,523 | 0.0% | 0.25% | +3.8% |
| Q4 2022 | $228,909 | +6.0% | 2,523 | -1.2% | 0.24% | +10.7% |
| Q2 2022 | $216,000 | -11.8% | 2,553 | -8.6% | 0.22% | -0.5% |
| Q1 2022 | $245,000 | +0.4% | 2,793 | 0.0% | 0.22% | +10.2% |
| Q4 2021 | $244,000 | +7.0% | 2,793 | 0.0% | 0.20% | +6.5% |
| Q3 2021 | $228,000 | -10.6% | 2,793 | 0.0% | 0.18% | -10.7% |
| Q2 2021 | $255,000 | +6.7% | 2,793 | 0.0% | 0.21% | -1.0% |
| Q1 2021 | $239,000 | -9.5% | 2,793 | -0.1% | 0.21% | -15.8% |
| Q4 2020 | $264,000 | +2833.3% | 2,797 | +2697.0% | 0.25% | +1664.3% |
| Q3 2015 | $9,000 | -10.0% | 100 | 0.0% | 0.01% | +75.0% |
| Q2 2015 | $10,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,000 | +11.1% | 100 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $9,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |